{
    "2019-04-11": [
        [
            {
                "time": "",
                "original_text": "【科创板大阅兵】多家A股药企是客户，美迪西研发人员占总员工81%，还在招兵买马！",
                "features": {
                    "keywords": [
                        "科创板",
                        "A股药企",
                        "美迪西",
                        "研发人员",
                        "招兵买马"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "瑞银：升药明康德(02359.HK)目标价至121.76港元 评级“买入”",
                "features": {
                    "keywords": [
                        "瑞银",
                        "药明康德",
                        "目标价",
                        "买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德:业绩保持高增长,一体化、端到端赋能平台价值凸显",
                "features": {
                    "keywords": [
                        "药明康德",
                        "高增长",
                        "一体化",
                        "端到端",
                        "赋能平台"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}